Miner JH - Search Results

1

Clinical trial recommendations for potential Alport syndrome therapies.

Weinstock BA, Feldman DL, Fornoni A, Gross O, Kashtan CE, Lagas S, Lennon R, Miner JH, Rheault MN, Simon JF; Workshop Participants. Weinstock BA, et al. Among authors: miner jh. Kidney Int. 2020 Jun;97(6):1109-1116. doi: 10.1016/j.kint.2020.02.029. Epub 2020 Apr 6. Kidney Int. 2020. PMID: 32386680 Free PMC article.

2

Alport syndrome with diffuse leiomyomatosis. When and when not?

Miner JH. Miner JH. Am J Pathol. 1999 Jun;154(6):1633-5. doi: 10.1016/S0002-9440(10)65417-X. Am J Pathol. 1999. PMID: 10362786 Free PMC article. No abstract available.

3

Abnormal glomerular basement membrane laminins in murine, canine, and human Alport syndrome: aberrant laminin alpha2 deposition is species independent.

Kashtan CE, Kim Y, Lees GE, Thorner PS, Virtanen I, Miner JH. Kashtan CE, et al. Among authors: miner jh. J Am Soc Nephrol. 2001 Feb;12(2):252-260. doi: 10.1681/ASN.V122252. J Am Soc Nephrol. 2001. PMID: 11158215

4

Of laminins and delamination in Alport syndrome.

Miner JH. Miner JH. Kidney Int. 2003 Mar;63(3):1158-9. doi: 10.1046/j.1523-1755.2003.00841.x. Kidney Int. 2003. PMID: 12631102 Free article. Review. No abstract available.

5

Transgenic isolation of skeletal muscle and kidney defects in laminin beta2 mutant mice: implications for Pierson syndrome.

Miner JH, Go G, Cunningham J, Patton BL, Jarad G. Miner JH, et al. Development. 2006 Mar;133(5):967-75. doi: 10.1242/dev.02270. Epub 2006 Feb 1. Development. 2006. PMID: 16452099 Free PMC article.

6

Proteinuria precedes podocyte abnormalities inLamb2-/- mice, implicating the glomerular basement membrane as an albumin barrier.

Jarad G, Cunningham J, Shaw AS, Miner JH. Jarad G, et al. Among authors: miner jh. J Clin Invest. 2006 Aug;116(8):2272-9. doi: 10.1172/JCI28414. J Clin Invest. 2006. PMID: 16886065 Free PMC article.

7

Choosing a mouse model to study the molecular pathobiology of Alport glomerulonephritis.

Cosgrove D, Kalluri R, Miner JH, Segal Y, Borza DB. Cosgrove D, et al. Among authors: miner jh. Kidney Int. 2007 Apr;71(7):615-8. doi: 10.1038/sj.ki.5002115. Epub 2007 Feb 7. Kidney Int. 2007. PMID: 17290292 Free article. Review.

8

Disruption of glomerular basement membrane charge through podocyte-specific mutation of agrin does not alter glomerular permselectivity.

Harvey SJ, Jarad G, Cunningham J, Rops AL, van der Vlag J, Berden JH, Moeller MJ, Holzman LB, Burgess RW, Miner JH. Harvey SJ, et al. Among authors: miner jh. Am J Pathol. 2007 Jul;171(1):139-52. doi: 10.2353/ajpath.2007.061116. Am J Pathol. 2007. PMID: 17591961 Free PMC article.

9

Podocyte-specific deletion of dicer alters cytoskeletal dynamics and causes glomerular disease.

Harvey SJ, Jarad G, Cunningham J, Goldberg S, Schermer B, Harfe BD, McManus MT, Benzing T, Miner JH. Harvey SJ, et al. Among authors: miner jh. J Am Soc Nephrol. 2008 Nov;19(11):2150-8. doi: 10.1681/ASN.2008020233. Epub 2008 Sep 5. J Am Soc Nephrol. 2008. PMID: 18776121 Free PMC article.

10

The Pax3-Cre transgene exhibits a rostrocaudal gradient of expression in the skeletal muscle lineage.

Jarad G, Miner JH. Jarad G, et al. Among authors: miner jh. Genesis. 2009 Jan;47(1):1-6. doi: 10.1002/dvg.20447. Genesis. 2009. PMID: 18942111 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

260 results

Search Page